Andrew Boon Ming Lim

Loading... 2 0 20 0 false
Credit Name
Andrew Boon Ming Lim
Full Name
Lim, Andrew Boon Ming
Loading... 3 0 20 0 false


Results 1-8 of 8 (Search time: 0.008 seconds).

Publication YearTitleAuthor(s)
1Aug-2023The prognostic impact of t(11;14) in multiple myeloma: A real-world analysis from the Australian Lymphoma Leukaemia Group (ALLG) and the Australian Myeloma and Related Diseases Registry (MRDR).Lim, Kenneth Jc; Wellard, Cameron; Talaulikar, Dipti; Tan, Joanne Lc; Loh, Joanna; Puvanakumar, Pratheepan; Kuzich, James A; Ho, Michelle; Murphy, Matthew; Zeglinas, Nicole; Low, Michael Sy; Routledge, David; Lim, Andrew Boon Ming ; Gibbs, Simon D; Quach, Hang; Morgan, Sue; Moore, Elizabeth; Ninkovic, Slavisa
2Jun-2023Predictors and outcomes of dose reduction of methotrexate and cyclosporin graft-versus-host disease prophylaxis following allogeneic haemopoietic cell transplantation.Ramanan, Radha; Lim, Andrew Boon Ming ; Tan, Joanne L C; Barmanray, Rahul D; Mason, Kate; Collins, Jenny; Hillman, Matthew; Szer, Jeff; Bajel, Ashish; Ritchie, David
32023Augmented ICE in Patients With Poor-Risk Refractory and Relapsed Lymphomas.Loo, Sun; Lim, Andrew Boon Ming ; Lee, Sze Ting ; Grigg, Andrew P 
42-Jun-2022Isatuximab plus carfilzomib and dexamethasone versus carfilzomib and dexamethasone in elderly patients with relapsed multiple myeloma: IKEMA subgroup analysis.Facon, Thierry; Moreau, Philippe; Martin, Thomas G; Spicka, Ivan; Oriol, Albert; Koh, Youngil; Lim, Andrew Boon Ming ; Mikala, Gabor; Rosiñol, Laura; Yağci, Münci; Cavo, Michele; Yong, Kwee; Risse, Marie-Laure; Asset, Gaëlle; Schwab, Sandrine; Martinez, Gracia
5May-2022Impact of a policy to improve the management of oral medications when patients are fasting before a procedure: an interrupted time series analysis.To, The-Phung ; Braat, Sabine; Lim, Andrew Boon Ming ; Brien, Jo-Anne; Heland, Melodie J ; Hardidge, Andrew J ; Story, David A 
6Sep-2021The association of mobilising regimen on immune reconstitution and survival in myeloma patients treated with bortezomib, cyclophosphamide and dexamethasone induction followed by a melphalan autograft.Rees, Matthew J ; Mollee, Peter; Ng, Jun Yen; Murton, Alex; Gonsalves, Jose Filipe; Panigrahi, Ashish; Beer, Hayley; Loh, Joanna; Nguyen, Philip; Hunt, Sam; Jina, Hayden; Wayte, Rebecca; Sutrave, Gaurav; Tan, Jocelyn; Abeyakoon, Chathuri; Chee, Ashlyn; Augustson, Bradley; Kalro, Akash; Lee, Cindy; Agrawal, Shivam; Churilov, Leonid ; Chua, Chong Chyn ; Lim, Andrew Boon Ming ; Zantomio, Daniela ; Grigg, Andrew P 
720-Feb-2021Prognostic performance of qSOFA in oncology patients admitted to the emergency department with suspected infection.Koh, Tze Lui ; Canet, Emmanuel; Amjad, Sobia; Bellomo, Rinaldo ; Taylor, David McD ; Gan, Hui K ; Marhoon, Nada ; Lim, Andrew Boon Ming ; Ong, Wee Loon ; Krishnan, Vivek; Khor, Richard 
8Sep-2019Pembrolizumab plus lenalidomide and dexamethasone for patients with treatment-naive multiple myeloma (KEYNOTE-185): a randomised, open-label, phase 3 trial.Usmani, Saad Zafar; Schjesvold, Fredrik; Oriol, Albert; Karlin, Lionel; Cavo, Michele; Rifkin, Robert M; Yimer, Habte Aragaw; LeBlanc, Richard; Takezako, Naoki; McCroskey, Robert Donald; Lim, Andrew Boon Ming ; Suzuki, Kenshi; Kosugi, Hiroshi; Grigoriadis, George; Avivi, Irit; Facon, Thierry; Jagannath, Sundar; Lonial, Sagar; Ghori, Razi Uddin; Farooqui, Mohammed Z H; Marinello, Patricia; San-Miguel, Jesus